Bookmark and Share
Print Friendly and PDF

Drug Discovery Initiative

Blocking rejection

Alternate Content Title

Alternate content supporting alternate title

Get Adobe Flash player

 

What the animation shows



The small green, yellow and blue strands at the center of this 3-dimensional structure comprise the CD-154 co-stimulatory molecule which plays a central role in the rejection process.

The three longer strands are the antibody used to successfully block the signal in previous studies. However, these antibodies caused side effects that could be eliminated if adequate small molecules can be identified.

This is a major focus of the DRI’s Drug Discovery team.
 

Diabetes Research Institute Foundation
200 S. Park Road, Suite 100
Hollywood, FL 33021
[P]   (954) 964-4040
[TF] (800) 321-3437
[F]   (954) 964-7036

Join Us on FacebookWatch us on YouTubeFollow Us on Twitter

BBB Wise Giving Alliance Accredited Charity  The Diabetes Research Institute Foundation is a Gold Level Participant on the GuideStar Exchange.  The Blue Circle - the global symbol for diabetes

Home | LoginDRInsider Sign Up | Site MapSite Search Contact UsDirectionsRecommended LinksPrivacy and Terms of Use | Mission Statements

© 2016 Diabetes Research Institute Foundation - National Office: 200 S. Park Road, Suite 100, Hollywood, FL 33021 - (954) 964-4040

Miller School of Medicine